Atlas Trials

AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD)

Clinical trial NCT01215279 · COMPLETED

Trial details

NCT number
NCT01215279
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary DiseaseLung Disease
Start date
2010-10-01
Primary completion
2011-03-01
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.